Text Size

Changes of Endothelial Function Before and After DSA in Patients With Diabetes

This study is currently recruiting participants.
Verified August 2012 by Wuhan General Hospital of Guangzhou Military Command
Sponsor:
Information provided by (Responsible Party):
Xiang Guang-da, Wuhan General Hospital of Guangzhou Military Command
ClinicalTrials.gov Identifier:
NCT01556984
First received: March 15, 2012
Last updated: September 2, 2012
Last verified: August 2012
History of Changes
  Purpose

Endothelial dysfunction is the early step of atherosclerosis. Therefore, the investigators hypothesize that digital subtraction angiography (DSA) can damage endothelial function. In this study, the investigators will select 200 diabetic patients who have a DSA for diabetic foot screening. Also, the investigators will select 100 healthy subjects as controls. The endothelial function will be determined by high resolution ultrasound before and after DSA. The investigators will observe the changes of endothelial function after DSA assay.


Condition Intervention
Diabetes
 Other: DSA assay

Study Type: Observational
Study Design: Observational Model: Case Control
Time Perspective: Prospective
Official Title: Changes of Endothelial Function Before and After DSA in Patients With Diabetes

Resource links provided by NLM:

U.S. FDA Resources

Further study details as provided by Wuhan General Hospital of Guangzhou Military Command:

Estimated Enrollment: 200
Study Start Date: January 2007
Estimated Primary Completion Date: September 2012 (Final data collection date for primary outcome measure)
Groups/Cohorts Assigned Interventions
DSA group Other: DSA assay
All patients with diabetic foot perform a DSA assay. Before and after DSA, endothelial function will be measured.
control group

  Eligibility

Ages Eligible for Study:   40 Years to 70 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   Yes
Sampling Method:   Probability Sample
Study Population

We will select 200 patients with diabetes. DSA will be taken for this group. Endothelial function will be measured before and after DSA. In the meantime, 100 healthy subjects will be selected as controls.

Criteria

Inclusion Criteria:

  • Patients with diabetic foot
  • Age 40 to 70 years old

Exclusion Criteria:

  • Heart failure
  • Renal failure
  • Acute infection
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT01556984

Contacts
Contact: Xiang Guangda, MD +862768878410 Guangda64@hotmail.com

Locations
China, Hubei
Wuhan General Hospital Recruiting
Wuhan, Hubei, China, 430070
Contact: Yue Ling, MD     +862768878410     Yueling@med.mail.com    
Sponsors and Collaborators
Wuhan General Hospital of Guangzhou Military Command
  More Information

No publications provided

Responsible Party: Xiang Guang-da, Director of Wuhan General Hospital, Wuhan General Hospital of Guangzhou Military Command
ClinicalTrials.gov Identifier: NCT01556984     History of Changes
Other Study ID Numbers: wz2010007
Study First Received: March 15, 2012
Last Updated: September 2, 2012
Health Authority: Ethics Committee:China

Keywords provided by Wuhan General Hospital of Guangzhou Military Command:
diabetic foot
digital subtraction angiography
endothelial function
 Patients with diabetes
Age 40 to 70 years old
Endothelial function are determined

Additional relevant MeSH terms:
Diabetes Mellitus
Glucose Metabolism Disorders
Metabolic Diseases
Endocrine System Diseases

ClinicalTrials.gov processed this record on June 18, 2013